Cases & Cleveland Clinic: Accelerating Research with AI & Quantum IT
- COLUMBUS, Ohio (April 7, 2025) – CAS, a division of the American Chemical Society specializing in scientific content management, and the Cleveland Clinic, a global health system, have...
- The announcement was made at the Cleveland Discovery & Innovation Forum, which highlights research in health care and life sciences.
- Lara Jehi, senior manager of search results for the Cleveland Clinic, emphasized the importance of the collaboration.
“`html
CAS and Cleveland Clinic Partner to Advance Clinical Research
Table of Contents
- CAS and Cleveland Clinic Partner to Advance Clinical Research
- CAS adn cleveland Clinic Partner to Advance Clinical Research
- What is the Goal of the CAS and Cleveland Clinic Partnership?
- What are the Key Areas of Focus for This Collaboration?
- How Will the Partnership Combine Expertise?
- How Will Data and Technology Be Leveraged?
- What Diseases Will Be Targeted Initially?
- What is the Meaning of Targeting Brain Health?
- What is the Role of CAS in This Partnership?
- What is the Cleveland Clinic’s Role in This partnership?
- What is the Benefit to Patients?
- What is Manuel Guzman’s (President of CAS) Perspective on the Partnership?
- Key Takeaways: Comparing the Partnership’s Components
COLUMBUS, Ohio (April 7, 2025) – CAS, a division of the American Chemical Society specializing in scientific content management, and the Cleveland Clinic, a global health system, have announced a strategic collaboration.The partnership aims to combine their expertise, technology, and data to accelerate clinical research.
Focus on Healthy Aging and Brain Health
The announcement was made at the Cleveland Discovery & Innovation Forum, which highlights research in health care and life sciences. The initial focus of the collaboration will be on advancing health, well-being, and healthy aging. A primary project will center on discovering drugs for brain health, an area with a significant need for effective treatments due to its complexity.
Combining Expertise for Better Patient Care
Dr. Lara Jehi, senior manager of search results for the Cleveland Clinic, emphasized the importance of the collaboration. “This unique collaboration is based on the expertise of the Cleveland Clinic in biomedical research and clinical care,as well as on the leadership of CAS in the field of scientific data and technology,” jehi said. “By uniting our forces, we aim to create high-quality medical data, to validate scientific models, and to integrate research in order to improve patient care and chronic disease management.”
leveraging Data and Technology
The initiative will utilize the CAS Content Collection, a curated details resource, along with advanced technologies, including AI and quantum computing. The Cleveland Clinic has an IBM quantum System One dedicated to health research as part of its partnership with IBM.
Alzheimer’s Disease as Initial Target
The organizations plan to develop and train models specific to diseases, starting with Alzheimer’s. The goal is to advance preventive and predictive strategies, with potential applications to other chronic diseases in the future.
CAS is delighted to associate with the Cleveland Clinic, an institution renowned for its exceptional research and innovation.
Manuel Guzman,president of CAS
Manuel Guzman,president of CAS,expressed enthusiasm for the partnership. “Knowing that it takes 17 years for a laboratory scientific discovery to become an approved test or treatment, we are convinced that together, we can fill this gap,” Guzman said. “Guided by our common goal of improving the lives of people thanks to scientific innovation, we will combine high
CAS adn cleveland Clinic Partner to Advance Clinical Research
Published: COLUMBUS,Ohio (April 7,2025) – CAS,a division of the American Chemical Society,and the Cleveland Clinic have announced a collaboration to accelerate clinical research. This partnership aims to leverage the strengths of both organizations to improve patient care and advance scientific discovery.
What is the Goal of the CAS and Cleveland Clinic Partnership?
The primary goal of this collaboration is to combine expertise, technology, and data to accelerate clinical research, ultimately leading to improved patient care and chronic disease management. The partnership intends to create high-quality medical data and validate scientific models.
What are the Key Areas of Focus for This Collaboration?
The initial focus will be on two primary areas:
- Healthy Aging: Advancing research in health, well-being, and healthy aging.
- Brain Health: Discovering new treatments for brain health, recognizing the complexity and important need in this area.
How Will the Partnership Combine Expertise?
The collaboration brings together the Cleveland Clinic’s expertise in biomedical research and clinical care with CAS’s leadership in scientific data and technology. This combination aims to:
- Create high-quality medical data.
- Validate scientific models.
- Integrate research findings to improve patient care.
How Will Data and Technology Be Leveraged?
The partnership will utilize several advanced technologies:
- CAS Content Collection: A curated data resource.
- Artificial Intelligence (AI): For data analysis and model progress.
- Quantum Computing: The Cleveland Clinic utilizes the IBM quantum System One for health research as part of its existing partnership with IBM.
What Diseases Will Be Targeted Initially?
The organizations plan to develop models starting with Alzheimer’s disease to advance preventive and predictive strategies. The goal is to extend these strategies to other chronic diseases in the future.
What is the Meaning of Targeting Brain Health?
Brain health is a significant area of focus due to the complexity of brain disorders and the need for effective treatments. This collaboration aims to address this critical need by discovering new drugs and developing innovative treatment approaches.
What is the Role of CAS in This Partnership?
CAS (Chemical Abstracts Service) brings to the partnership its expertise in scientific content management, data analytics, and technology. Their curated data resources will be crucial in advancing the research efforts.
What is the Cleveland Clinic’s Role in This partnership?
the Cleveland Clinic contributes its extensive experience in biomedical research and clinical care. They will provide the clinical expertise and data necessary to validate scientific models and improve patient care.
What is the Benefit to Patients?
The ultimate goal is to improve patient care and chronic disease management. This includes:
- Developing better preventive and predictive strategies.
- Accelerating the discovery of new treatments.
- Improving overall health outcomes.
What is Manuel Guzman’s (President of CAS) Perspective on the Partnership?
Manuel Guzman expressed enthusiasm, emphasizing that the collaboration aims to reduce the time it takes for scientific discoveries to become treatments. He believes that together, CAS and the Cleveland Clinic can fill this gap and improve lives through scientific innovation.
CAS is delighted to associate with the Cleveland Clinic, an institution renowned for its extraordinary research and innovation.
Manuel Guzman, president of CAS
Key Takeaways: Comparing the Partnership’s Components
| Component | Description |
|---|---|
| Partners | CAS (a division of the American Chemical Society) & Cleveland Clinic |
| Primary Focus | Accelerating clinical research to improve patient care. |
| Initial Areas of Research | Healthy Aging and Brain Health |
| Technology to be Used | CAS Content Collection, AI, Quantum Computing (IBM system One) |
| Initial Disease Target | Alzheimer’s Disease |
| Expected Outcomes | Improved disease prevention, new treatments, and better patient outcomes. |
By combining cutting-edge technology, rich data resources, and clinical expertise, this partnership has the potential to considerably impact the future of healthcare and improve the lives of patients. The focus on brain health and Alzheimer’s disease specifically highlights their commitment to addressing areas with substantial unmet needs.